{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:49:33Z","timestamp":1769438973872,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1245\/s10434-019-08104-1","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T17:03:49Z","timestamp":1575911029000},"page":"1617-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients"],"prefix":"10.1245","volume":"27","author":[{"given":"Andrea V.","family":"Barrio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Downs-Canner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Edelweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Van Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Hiram S.","family":"Cody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Plitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"El-Tamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Kirstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Capko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"12","key":"8104_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"10","key":"8104_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"6","key":"8104_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305(6):569\u201375.","journal-title":"JAMA"},{"issue":"3","key":"8104_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","volume":"266","author":"M Morrow","year":"2017","unstructured":"Morrow M, Van Zee KJ, Patil S, et al. Axillary dissection and nodal irradiation can be avoided for most node-positive z0011-eligible breast cancers: a prospective validation study of 793 patients. Ann Surg 2017;266(3):457\u201362.","journal-title":"Ann Surg"},{"issue":"3","key":"8104_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1054\/brst.2000.0233","volume":"10","author":"JA Bucci","year":"2001","unstructured":"Bucci JA, Kennedy CW, Burn J, et al. Implications of extranodal spread in node positive breast cancer: a review of survival and local recurrence. Breast 2001;10(3):213\u20139.","journal-title":"Breast"},{"issue":"7","key":"8104_CR6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ejso.2016.02.259","volume":"42","author":"A Nottegar","year":"2016","unstructured":"Nottegar A, Veronese N, Senthil M, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur J Surg Oncol 2016;42(7):919\u201325.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"8104_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0360-3016(95)00081-9","volume":"33","author":"LJ Pierce","year":"1995","unstructured":"Pierce LJ, Oberman HA, Strawderman MH, Lichter AS. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy? Int J Radiat Oncol Biol Phys 1995;33(2):253\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"8104_CR8","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1245\/s10434-014-3752-0","volume":"21","author":"J Gooch","year":"2014","unstructured":"Gooch J, King TA, Eaton A, et al. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol 2014;21(9):2897\u2013903.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"8104_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejso.2011.01.006","volume":"37","author":"RF van la Parra","year":"2011","unstructured":"van la Parra RF, Peer PG, Ernst MF, Bosscha K. Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol 2011;37(4):290\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"8104_CR10","doi-asserted-by":"publisher","first-page":"e0171853","DOI":"10.1371\/journal.pone.0171853","volume":"12","author":"S Aziz","year":"2017","unstructured":"Aziz S, Wik E, Knutsvik G, et al. Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. PLoS ONE 2017;12(2):e0171853.","journal-title":"PLoS ONE"},{"key":"8104_CR11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141\u201354.","journal-title":"Ann Stat"},{"key":"8104_CR12","doi-asserted-by":"crossref","unstructured":"Rutgers EJ, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10\u00a0year follow up results of the EORTC AMAROS trial (EORTC 10981\/22023) [abstract no. GS4-01]. 41st Annual San Antonio Breast Cancer Symposium, 4\u20138 Dec 2018; San Antonio, TX.","DOI":"10.1158\/1538-7445.SABCS18-GS4-01"},{"issue":"12","key":"8104_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jamasurg.2015.1687","volume":"150","author":"AH Choi","year":"2015","unstructured":"Choi AH, Blount S, Perez MN, et al. Size of extranodal extension on sentinel lymph node dissection in the American College of Surgeons Oncology Group Z0011 trial era. JAMA Surg 2015;150(12):1141\u20138.","journal-title":"JAMA Surg"},{"issue":"1","key":"8104_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0360-3016(99)00424-1","volume":"46","author":"S Hetelekidis","year":"2000","unstructured":"Hetelekidis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer. Int J Radiat Oncol Biol Phys 2000;46(1):31\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8104_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1200\/JCO.1995.13.1.47","volume":"13","author":"C Leonard","year":"1995","unstructured":"Leonard C, Corkill M, Tompkin J, et al. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. J Clin Oncol 1995;13(1):47\u201353.","journal-title":"J Clin Oncol"},{"issue":"3","key":"8104_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0360-3016(97)89483-7","volume":"38","author":"BJ Fisher","year":"1997","unstructured":"Fisher BJ, Perera FE, Cooke AL, et al. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Int J Radiat Oncol Biol Phys 1997;38(3):551\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8104_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 2016;264(3):413\u201320.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-08104-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:52:58Z","timestamp":1607388778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-08104-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["8104"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-08104-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"12 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Andrea V. Barrio has received speaking honoraria from Roche; Dr. Monica Morrow has received honoraria from Genomic Health and Roche; Dr. Kimberly J. Van Zee served on the advisory board of Genomic Health in 2012; and Dr. Mahmoud El-Tamer has received honoraria from Blue Earth Diagnostic. Stephanie Downs-Canner, Marcia Edelweiss, Hiram S. Cody III, Mary L. Gemignani, Melissa L. Pilewskie, George Plitas, Laurie Kirstein, Deborah Capko, and Sujata Patil have no conflict of interest disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}